Dark

Check out our API

CINC
CinCor Pharma, Inc. Common Stock
stock NASDAQ

Inactive

Feb 23, 2023

29.06USD-0.479%(-0.14)6,349,776

Pre-market

0.00USD-100.000%(-29.20)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 19, 2022

09:49AM EST CinCor Pharma's Ex-Dividend Date Is Sunday, Here's What You Need To Know Benzinga

Jan 13, 2022

08:00AM EST CinCor Pharma, Inc. (NASDAQ: CINC) today announced the appointment of the independent member June Lee, M.D. to the companys Board of Directors. Dr. Lee brings decades of leadership experience in the biotechnology and pharmaceutical industry and has served in numerous executive and board roles. GlobeNewswire Inc

Jan 7, 2022

01:08PM EST CinCor Pharma Shares Open For Trade At $21; IPO Priced $16/Share Benzinga

01:04PM EST IPOs For Friday, Jan. 7, 2022: Amylyx Pharmaceuticals, Priced $19; Hour Loop, Priced $4; Vigil Neuroscience, Priced $14; CinCor Pharma, Priced $16; Viscogliosi Brothers Acquisition, Priced $10 Benzinga

01:04PM EST CinCor Pharma Shares Will Open For Quote At 10:10 a.m. EST, Expected To Open For Trade After 10:20 a.m. EST; IPO Priced $16/Share Benzinga

01:03PM EST The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs Benzinga

Jan 6, 2022

11:37PM EST CinCor Pharma Prices IPO Of 12.1 Mln Shares At $16/Shr RTTNews

11:27PM EST CinCor Pharma Announces Pricing of Initial Public Offering GlobeNewswire Inc

Jan 3, 2022

07:30AM EST CinCor Pharma Launches Roadshow for Proposed Initial Public GlobeNewswire Inc

Share